Skip to main content
logo
Virpax Pharmaceuticals, Inc. (VRPX)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Sep 3, 2026, 4:00 PM EST

Virpax Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
1.519.141936.840.05
Cash & Short-Term Investments
1.519.141936.840.05
Cash Growth
-83.45%-51.88%-48.44%67134.82%31.92%
Prepaid Expenses
0.040.20.180.160.01
Other Current Assets
00.280.52.570
Total Current Assets
1.569.6319.6739.570.07
Long-Term Deferred Charges
----0.39
Total Assets
1.569.6319.6739.570.47

Liabilities

Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Accounts Payable
0.040.020.040.020.02
Accrued Expenses
2.431.681.062.073.08
Current Portion of Long-Term Debt
----0.54
Current Income Taxes Payable
----0.01
Other Current Liabilities
-62--
Total Current Liabilities
2.477.693.092.093.66
Long-Term Debt
----1.02
Total Liabilities
2.477.693.092.094.68

Shareholders' Equity

Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Common Stock
00000
Additional Paid-In Capital
70.761.4860.9360.196.43
Retained Earnings
-71.61-59.54-44.35-22.7-10.65
Shareholders' Equity
-0.911.9316.5837.48-4.22
Total Liabilities & Equity
1.569.6319.6739.570.47

Additional Metrics

Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Total Debt
----1.57
Net Cash (Debt)
1.519.141936.84-1.51
Net Cash Growth
-83.45%-51.88%-48.44%--
Net Cash Per Share
8.89195.13405.531379.38-121.54
Filing Date Shares Outstanding
1.060.050.050.050.02
Total Common Shares Outstanding
0.60.050.050.050.01
Working Capital
-0.911.9316.5837.48-3.59
Book Value Per Share
-1.5341.29353.82799.93-335.12
Tangible Book Value
-0.911.9316.5837.48-4.22
Tangible Book Value Per Share
-1.5341.29353.82799.93-335.12